AbbVie, Apogee Therapeutics filed HSR July 6, setting up Aug. 5 expiration
( July 13, 2026, 21:38 GMT | Official Statement) -- MLex Summary: AbbVie and Apogee Therapeutics each filed the required Hart-Scott-Rodino Act notification paperwork on July 6 for their merger, starting a 30-day waiting period for the US Federal Trade Commission and US Department of Justice to look into the deal. The waiting period is set to expire at 11:59 p.m. on Aug. 5 unless the paperwork is pulled and refiled, the companies receive early termination or a second request is issued.Excerpt follows:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.